// App-Quantinova.ai

2910 : Overcoming therapy resistance in SOX2-expressing head and neck squamous cell carcinoma cells by targeting the downstream BCL2-pathway

Researchers

Presenter

  • Hui Wang

Principal Investigators

  • Angela Quiesser

  • Andreas Schrock

  • Sven Perner

  • Claudia Lengerke

Medical Centers

  • University Hospital Basel, Department of Neurosurgery, Basel, Switzerland

  • University Hospital of Bonn, Department of Prostate Cancer Research and Institute of Pathology, Bonn, Germany

  • University Hospital of Bonn, Department of Otorhinolaryngology/Head and Neck Surgery, Bonn, Germany

  • Pathology of the University Hospital Luebeck and the Leibniz Research Center Borstel, Luebeck / Borstel, Germany

  • University Hospital Basel, Department of Biomedicine and University Hospital Basel, Clinic for Hematology, Basel, Switzerland.

Locations

  • Germany

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved